Clinical Trials Browser

Phase 2 × Completed × Carcinoma, Bronchogenic × Clear all

NCT02904954 2023-10-11

Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage I, II and IIIA Non-small Cell Lung Cancer

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT01058785 2010-07-29

Phase II Study of Lucanix™ in Patients With Stages II-IV Non-Small Cell Lung Cancer

Phase 2 Completed

75 enrolled

Thoracic

Carcinoma, Bronchogenic, Lung Neoplasms

NCT00196885 2008-06-20

Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training

Phase 2 Completed

60 enrolled

GastrointestinalLymphoid

Carcinoma, Bronchogenic, Gastrointestinal Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Muscular Atrophy, Weight Loss

NCT00407264 2006-12-04

Randomized Trial of Fluticasone in Bronchial Premalignancy

Phase 2 Completed

90 enrolled

Carcinoma, Bronchogenic